Abstract
Breast carcinomas are among the most frequent malignant tumors. Much research has been focused on the prognostic and predictive factors in breast carcinomas. However, the prognostic value of tumor deposits or extranodal metastasis was not evaluated in breast carcinomas to the best of our knowledge. Herein, tumor deposits of breast carcinoma cases are presented, and the lack of research in this field is highlighted.
This is a preview of subscription content, log in via an institution to check access.
References
Al Sahaf O, Myers E, Jawad M, Browne TJ, Winter DC, Redmond HP. The prognostic significance of extramural deposits and extracapsular lymph node invasion in colon cancer. Dis Colon Rectum. 2011;54(8):982–8. https://doi.org/10.1097/DCR.0b013e31821c4944.
Aquino RGF, Vasques PHD, Cavalcante DIM, Oliveira ALS, Oliveira BMK, Pinheiro LGP. Invasive ductal carcinoma: relationship between pathological characteristics and the presence of axillary metastasis in 220 cases. Rev Col Bras Cir. 2017;44(2):163–70. https://doi.org/10.1590/0100-69912017002010. English, Portuguese.
Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst. 2005;97:1254–61. https://doi.org/10.1093/jnci/dji249.
Badowska-Kozakiewicz AM, Budzik MP. Immunohistochemical characteristics of basal-like breast cancer. Contemp Oncol (Pozn). 2016;20(6):436–43. https://doi.org/10.5114/wo.2016.56938. Epub 2017 Jan 12. Review.
CAP. (2013). http://www.cap.org/ShowProperty?nodePath=/UCMCon/Contribution%20Folders/WebContent/pdf/colon-13protocol-3300.pdf. Accessed 24 April 2017.
CAP. (2017). http://www.cap.org/ShowProperty?nodePath=/UCMCon/Contribution%20Folders/WebContent/pdf/cp-breast-invasive-17protocol-4000.pdf. Accessed 13 Aug 2017.
Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Gräf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, METABRIC Group, Langerød A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Børresen-Dale AL, Brenton JD, Tavaré S, Caldas C, Aparicio S. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346–52. https://doi.org/10.1038/nature10983.
Durak MG, Akansu B, Akin MM, Sevınç AI, Koçdor MA, Saydam S, Harmancioğlu O, Ellıdokuz H, Bekış R, Canda T. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma. Turk Patoloji Derg. 2011;27(3):189–95. https://doi.org/10.5146/tjpath.2011.01074.
Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403–10.
Heng YJ, Lester SC, Tse GM, Factor RE, Allison KH, Collins LC, Chen YY, Jensen KC, Johnson NB, Jeong JC, Punjabi R, Shin SJ, Singh K, Krings G, Eberhard DA, Tan PH, Korski K, Waldman FM, Gutman DA, Sanders M, Reis-Filho JS, Flanagan SR, Gendoo DM, Chen GM, Haibe-Kains B, Ciriello G, Hoadley KA, Perou CM, Beck AH. The molecular basis of breast cancer pathological phenotypes. J Pathol. 2017;241(3):375–91. https://doi.org/10.1002/path.4847; Epub 2016 Dec 29.
Külahcı Ö, Esen HH, Asut E, Güngör S. Association of ICAM-1, VCAM-1, CYCLIN D1 and cathepsin D with clinicopathological parameters in breast carcinoma; an immunohistochemical study. J Breast Health (2013). 2017;13(1):5–9. https://doi.org/10.5152/tjbh.2016.3142; eCollection 2017 Jan.
Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. WHO classification of breast tumors. Lyon: IARC; 2012.
Meattini I, Desideri I, Saieva C, Francolini G, Scotti V, Bonomo P, Greto D, Mangoni M, Nori J, Orzalesi L, Fambrini M, Bianchi S, Livi L. Impact of sentinel node tumor burden on outcome of invasive breast cancer patients. Eur J Surg Oncol. 2014;40(10):1195–202. https://doi.org/10.1016/j.ejso.2014.08.471; Epub 2014 Aug 20.
Metzger R, Drebber U, Baldus SE, Mönig SP, Hölscher AH, Bollschweiler E. Extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus. Ann Surg Oncol. 2009;16(2):447–53. https://doi.org/10.1245/s10434-008-0248-9; Epub 2008 Nov 27.
Nottegar A, Veronese N, Senthil M, Roumen RM, Stubbs B, Choi AH, Verheuvel NC, Solmi M, Pea A, Capelli P, Fassan M, Sergi G, Manzato E, Maruzzo M, Bagante F, Koç M, Eryilmaz MA, Bria E, Carbognin L, Bonetti F, Barbareschi M, Luchini C. Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: a systematic review and an exploratory meta-analysis. Eur J Surg Oncol. 2016;42(7):919–25. https://doi.org/10.1016/j.ejso.2016.02.259; Epub 2016 Mar 10. Review.
Sarioglu S, Akbulut N, Iplikci S, Aydin B, Dogan E, Unlu M, Ellidokuz H, Ada E, Akman F, Ikiz AO. Tumor deposits in head and neck carcinomas. Head Neck. 2016;38(Suppl 1):E256–60. https://doi.org/10.1002/hed.23981; Epub 2015 Aug 21.
Tong ZJ, Shi NY, Zhang ZJ, Yuan XD, Hong XM. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis. Biosci Rep. 2017;37(4). https://doi.org/10.1042/BSR20170121; Print 2017 Aug 31.
van de Vijver MJ. Molecular tests as prognostic factors in breast cancer. Virchows Arch. 2014;464:283–91. https://doi.org/10.1007/s00428014-1539-0.
Vuong D, Simpson PT, Green B, Cummings MC, Lakhani SR. Molecular classification of breast cancer. Virchows Arch. 2014;465(1):1–14. https://doi.org/10.1007/s00428-014-1593-7; Epub 2014 May 31.
Walvekar RR, Andrade Filho PA, Seethala RR, Gooding WE, Heron DE, Johnson JT, Ferris RL. Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies. Head Neck. 2011;33(2):225–31.
Zhang HD, Tang P, Duan XF, Chen CG, Ma Z, Gao YY, Zhang H, Yu ZT. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction. J Surg Oncol. 2013;108(8):542–9.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Sarioglu, S. (2018). Tumor Deposits in Breast Carcinomas. In: Tumor Deposits. Springer, Cham. https://doi.org/10.1007/978-3-319-68582-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-68582-3_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-68581-6
Online ISBN: 978-3-319-68582-3
eBook Packages: MedicineMedicine (R0)